AQR Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Buy |
|
|||||
|
2025
Q1 | $942K | Sell |
|
|||||
|
2024
Q4 | $890K | Buy |
|
|||||
|
2024
Q3 | $919K | Sell |
|
|||||
|
2024
Q2 | $1.12M | Buy |
|
|||||
|
2024
Q1 | $837K | Buy |
|
|||||
|
2023
Q4 | $253K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $808K | Buy |
|
|||||
|
2021
Q4 | $354K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $685K | Sell |
|
|||||
|
2021
Q1 | $752K | Sell |
|
|||||
|
2020
Q4 | $994K | Sell |
|
|||||
|
2020
Q3 | $1.08M | Sell |
|
|||||
|
2020
Q2 | $1.78M | Sell |
|
|||||
|
2020
Q1 | $2.46M | Buy |
|
|||||
|
2019
Q4 | $473K | Buy |
|
|||||
|
2019
Q3 | $339K | Sell |
|
|||||
|
2019
Q2 | $544K | Sell |
|
|||||
|
2019
Q1 | $570K | Buy |
|
|||||
|
2018
Q4 | $326K | Sell |
|
|||||
|
2018
Q3 | $554K | Buy |
|
|||||
|
2018
Q2 | $537K | Sell |
|
|||||
|
2018
Q1 | $571K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $246K | Sell |
|
|||||
|
2017
Q1 | $262K | Buy |
|
|||||
|
2016
Q4 | $252K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $677K | Buy |
|
|||||
|
2016
Q1 | $356K | Sell |
|
|||||
|
2015
Q4 | $573K | Sell |
|
|||||
|
2015
Q3 | $783K | Sell |
|
|||||
|
2015
Q2 | $2.24M | Sell |
|
|||||
|
2015
Q1 | $2.68M | Sell |
|
|||||
|
2014
Q4 | $6.03M | Buy |
|
|||||
|
2014
Q3 | $2.67M | Buy |
|